Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc
(NQ:
LTRN
)
5.720
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
5.720
Bid (Size)
5.210 (5)
Ask (Size)
5.720 (1)
Prev. Close
5.720
Today's Range
5.720 - 5.720
52wk Range
2.380 - 11.99
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
April 22, 2024
From
Lantern Pharma Inc.
Via
Business Wire
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
April 19, 2024
Via
Benzinga
Performance
YTD
+37.17%
+37.17%
1 Month
-42.34%
-42.34%
3 Month
+38.16%
+38.16%
6 Month
+110.68%
+110.68%
1 Year
+23.28%
+23.28%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
Recap: Lantern Pharma Q4 Earnings
March 18, 2024
Via
Benzinga
Lantern Pharma Earnings Preview
March 15, 2024
Via
Benzinga
Software Segment of Global A.I. Healthcare Billion Dollar Market Expected to Have Fastest Growth
April 10, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
March 31, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
March 23, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028
March 20, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
March 18, 2024
Via
InvestorPlace
Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028
March 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
March 18, 2024
From
Lantern Pharma Inc.
Via
Business Wire
Earnings Scheduled For March 18, 2024
March 18, 2024
Via
Benzinga
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
March 15, 2024
From
Lantern Pharma Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
March 11, 2024
From
Lantern Pharma Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Via
Benzinga
Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
March 05, 2024
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines
March 04, 2024
From
Lantern Pharma Inc.
Via
Business Wire
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Via
Talk Markets
3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom
February 20, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.